Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- befree-2016 importedOn "2016-02-19" NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion wasGeneratedBy ECO_0000203 NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion wasDerivedFrom befree-2016 NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion SIO_000772 24222664 NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion evidence source_evidence_literature NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.